rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
2000-6-27
|
pubmed:abstractText |
To investigate the hemodynamic effects of the selective endothelin (ET)A receptor antagonist LU135252 in patients with congestive heart failure (CHF).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0735-1097
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1745-52
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10841220-Catecholamines,
pubmed-meshheading:10841220-Dose-Response Relationship, Drug,
pubmed-meshheading:10841220-Endothelin-1,
pubmed-meshheading:10841220-Female,
pubmed-meshheading:10841220-Heart Failure,
pubmed-meshheading:10841220-Hemodynamics,
pubmed-meshheading:10841220-Humans,
pubmed-meshheading:10841220-Male,
pubmed-meshheading:10841220-Middle Aged,
pubmed-meshheading:10841220-Phenylpropionates,
pubmed-meshheading:10841220-Pyrimidines,
pubmed-meshheading:10841220-Receptors, Endothelin
|
pubmed:year |
2000
|
pubmed:articleTitle |
Acute hemodynamic and neurohumoral effects of selective ET(A) receptor blockade in patients with congestive heart failure. ET 003 Investigators.
|
pubmed:affiliation |
Division of Cardiology, University Hospital, Zürich, Switzerland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|